These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1282000)

  • 1. Down regulation of CD4 expression in cultured microglia by immunosuppressants and lipopolysaccharide.
    Sawada M; Suzumura A; Marunouchi T
    Biochem Biophys Res Commun; 1992 Dec; 189(2):869-76. PubMed ID: 1282000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent.
    Jordan CA; Watkins BA; Kufta C; Dubois-Dalcq M
    J Virol; 1991 Feb; 65(2):736-42. PubMed ID: 1702842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression.
    Han CW; Imamura M; Hashino S; Zhu X; Tanaka J; Imai K; Matsudaira T; Asano S
    Bone Marrow Transplant; 1995 May; 15(5):733-9. PubMed ID: 7545487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells.
    Zawadzka M; Kaminska B
    Glia; 2005 Jan; 49(1):36-51. PubMed ID: 15390105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus (FK506) and cyclosporin A reduce macrophage recruitment to the rat brain injured at perinatal and early postnatal periods.
    Setkowicz Z; Caryk M; Szafraniec M; Zmudzińska A; Janeczko K
    Neurol Res; 2009 Dec; 31(10):1060-7. PubMed ID: 19138474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of cyclosporin A and FK506 from nitric oxide-dependent apoptosis in activated macrophages.
    Hortelano S; López-Collazo E; Boscá L
    Br J Pharmacol; 1999 Mar; 126(5):1139-46. PubMed ID: 10205001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide inhibits HIV-1 infection of monocyte- derived macrophages through direct and sustained down-regulation of CC chemokine receptor 5.
    Franchin G; Zybarth G; Dai WW; Dubrovsky L; Reiling N; Schmidtmayerova H; Bukrinsky M; Sherry B
    J Immunol; 2000 Mar; 164(5):2592-601. PubMed ID: 10679098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A and FK506 reduce interleukin-5 mRNA abundance by inhibiting gene transcription.
    Rolfe FG; Valentine JE; Sewell WA
    Am J Respir Cell Mol Biol; 1997 Aug; 17(2):243-50. PubMed ID: 9271313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting impacts of immunosuppressive agents (rapamycin, FK506, cyclosporin A, and dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation.
    Matsue H; Yang C; Matsue K; Edelbaum D; Mummert M; Takashima A
    J Immunol; 2002 Oct; 169(7):3555-64. PubMed ID: 12244145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 expression in neurons of the central nervous system.
    Omri B; Crisanti P; Alliot F; Marty MC; Rutin J; Levallois C; Privat A; Pessac B
    Int Immunol; 1994 Mar; 6(3):377-85. PubMed ID: 8186189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cyclosporin A and FK506 on nitric oxide and tetrahydrobiopterin synthesis in bacterial lipopolysaccharide-treated J774 macrophages.
    Hattori Y; Nakanishi N
    Cell Immunol; 1995 Oct; 165(1):7-11. PubMed ID: 7545550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain-specific differences in the effects of cyclosporin A and FK506 on the survival and regeneration of axotomized retinal ganglion cells in adult rats.
    Cui Q; Hodgetts SI; Hu Y; Luo JM; Harvey AR
    Neuroscience; 2007 May; 146(3):986-99. PubMed ID: 17408862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.
    Miyazaki M; Fujikawa Y; Takita C; Tsumura H
    Clin Rheumatol; 2007 Feb; 26(2):231-9. PubMed ID: 16586042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK506 enhanced osteoblastic differentiation in mesenchymal cells.
    Tang L; Ebara S; Kawasaki S; Wakabayashi S; Nikaido T; Takaoka K
    Cell Biol Int; 2002; 26(1):75-84. PubMed ID: 11779223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular signaling mechanisms for stimulation of growth hormone secretion and growth hormone primary transcripts by immunosuppressant agents, FK506 and cyclosporin A, in cultured rat pituitary cells.
    Ohye H; Sato M; Murao K; Matsubara S; Tokuda M; Takahara J
    Neuroimmunomodulation; 1998; 5(6):309-17. PubMed ID: 9762012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of FK 506 and cyclosporin A on nitric oxide production by LPS-treated cultured rat macrophages.
    Strestíková P; Otová B; Filipec M; Farghali H
    Physiol Res; 2000; 49(6):725-8. PubMed ID: 11252540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia.
    Stalder AK; Pagenstecher A; Yu NC; Kincaid C; Chiang CS; Hobbs MV; Bloom FE; Campbell IL
    J Immunol; 1997 Aug; 159(3):1344-51. PubMed ID: 9233631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential anti-inflammatory effects of immunosuppressive drugs: cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production.
    Attur MG; Patel R; Thakker G; Vyas P; Levartovsky D; Patel P; Naqvi S; Raza R; Patel K; Abramson D; Bruno G; Abramson SB; Amin AR
    Inflamm Res; 2000 Jan; 49(1):20-6. PubMed ID: 10778917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of CXCR4-tropic HIV-1 infection by lipopolysaccharide: evidence of different mechanisms in macrophages and T lymphocytes.
    Verani A; Sironi F; Siccardi AG; Lusso P; Vercelli D
    J Immunol; 2002 Jun; 168(12):6388-95. PubMed ID: 12055257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FK506 protects against various immune responses and secondary degeneration following cerebral ischemia.
    Brecht S; Waetzig V; Hidding U; Hanisch UK; Walther M; Herdegen T; Neiss WF
    Anat Rec (Hoboken); 2009 Dec; 292(12):1993-2001. PubMed ID: 19728359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.